[1] WONG R, RENETTE C. Updates in the management of hepatocellular carcinoma[J]. Gastroenterol Hepatol(NY), 2011, 7(1): 16.
[2] SAUZAY C, PETIT A, BOURGEOISA M, et al. Alpha-foe-toprotein(AFP): A multi-purposemarker in hepatocellular carcinoma[J]. Clin Chim Acta, 2016, 463(1): 39.
[3] LI X, CHEN ZH, XING YF, et al. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma[J]. Tumour Biol, 2015, 36(4): 2263. doi: 10.1007/s13277-014-2833-9
[4] PENG W, LI C, ZHU WJ, et al. Prognostic value of the platelet to lymphocyte ratio change in liver cancer[J]. J Surg Res, 2015, 194(2): 464. doi: 10.1016/j.jss.2014.12.021
[5] XUE TC, JIA QA, GEN L, et al. The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization[J]. Tumour Biol, 2015, 36(8): 6045. doi: 10.1007/s13277-015-3281-x
[6] GRIVENNIKOV SI, GRETEN FR, KARIN M. Immunity, inflammation, and cancer[J]. Cell, 2010, 140(6): 883. doi: 10.1016/j.cell.2010.01.025
[7] LI H, ZHAO Y, ZHENG F. Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery: a Meta-analysis[J]. Medicine, 2019, 98(3): e14126. doi: 10.1097/MD.0000000000014126
[8] HU RJ, MA JY, HU G. Lymphocyte-to-monocyte ratio in pancreatic cancer: prognostic significance and meta-analysis[J]. Clin Chim Acta, 2018, 481: 142. doi: 10.1016/j.cca.2018.03.008
[9] FANG Y, XU C, WU P, et al. Prognostic role of C-reactive protein in patients with nasopharyngeal carcinoma: a Meta analysis and literature review[J]. Medicine, 2017, 96(45): e8463. doi: 10.1097/MD.0000000000008463
[10] TEMPLETON AJ, ACE O, MANAMARA MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and Meta-analysis[J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(7): 1204. doi: 10.1158/1055-9965.EPI-14-0146
[11] SALMAN T, KAZAZ SN, VAROL U, et al. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for patients with neuroendocrine tumors: an izmir oncology group study[J]. Chemotherapy, 2015, 61(6): 281.
[12] 刘凌云, 何沙, 卢永刚. 联合检测血清AFU、AFP、β2-MG、CA199及CEA对原发性肝癌诊断的临床意义[J]. 海南医学, 2013, 24(13): 1948. doi: 10.3969/j.issn.1003-6350.2013.13.0806
[13] 赵惠柳, 舒宏, 欧超, 等. 原发性肝癌病人血清高尔基蛋白73、铁蛋白、甲胎蛋白联合检测的早期诊断价值分析[J]. 蚌埠医学院学报, 2020, 45(2): 246.
[14] 代维, 李志清, 姜红峰, 等. 血清AFP、CA19-9、CA125、CEA、γ-GT联合检测对原发性肝癌的诊断价值[J]. 华中医学杂志, 2007, 31(2): 143.
[15] 吴建民. 对肿瘤标志物再认识[J]. 中华检验医学杂志, 2005, 28(1): 11. doi: 10.3760/j:issn:1009-9158.2005.01.005